Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by Everett Harris & Co. CA

Everett Harris & Co. CA grew its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 15.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 148,542 shares of the company's stock after buying an additional 19,600 shares during the quarter. Everett Harris & Co. CA owned 0.12% of Henry Schein worth $10,829,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Swedbank AB purchased a new position in Henry Schein during the first quarter worth $215,998,000. Thompson Siegel & Walmsley LLC purchased a new stake in Henry Schein in the 2nd quarter worth about $46,683,000. SG Americas Securities LLC lifted its stake in Henry Schein by 1,622.3% in the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company's stock worth $33,449,000 after purchasing an additional 432,187 shares during the last quarter. Nuance Investments LLC boosted its position in shares of Henry Schein by 28.5% during the first quarter. Nuance Investments LLC now owns 1,755,190 shares of the company's stock valued at $132,552,000 after buying an additional 388,843 shares during the period. Finally, Magnetar Financial LLC boosted its position in shares of Henry Schein by 229.9% during the first quarter. Magnetar Financial LLC now owns 386,458 shares of the company's stock valued at $29,185,000 after buying an additional 269,330 shares during the period. Institutional investors own 96.62% of the company's stock.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company's stock, valued at $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 1.14% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Baird R W raised Henry Schein from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 22nd. JPMorgan Chase & Co. cut their price target on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a report on Monday, August 12th. Robert W. Baird decreased their price objective on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a report on Wednesday, August 7th. Evercore ISI upped their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $82.00 price target on shares of Henry Schein in a research note on Friday, September 20th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $77.50.

Henry Schein Stock Up 1.0 %

Henry Schein stock traded up $0.72 during mid-day trading on Friday, reaching $72.39. 688,164 shares of the company were exchanged, compared to its average volume of 1,335,087. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The firm has a market cap of $9.27 billion, a P/E ratio of 24.46, a PEG ratio of 1.98 and a beta of 0.86. The business has a fifty day moving average of $70.40 and a 200 day moving average of $69.90. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping analysts' consensus estimates of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm had revenue of $3.10 billion during the quarter, compared to analysts' expectations of $3.27 billion. During the same period in the prior year, the business posted $1.31 EPS. The firm's quarterly revenue was up .0% on a year-over-year basis. Research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.